Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Print  

Study Name: Glutamine Supplementation for Cystic Fibrosis
Study Type: Interventional
Intervention Category: Anti-Inflammatory
Study Sponsor: Fogarty, Andrew

Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase: 2
Recruitment Status: Trial Completed
Study Drug(s): Glutamine
Number of Participants Being Recruited: 44
Single / Multi-Center: Single Center
STUDY BACKGROUND INFORMATION:
This study willevaluate the safety and tolerability of aerolized glutathione compared with normal saline. The main outcome measure is pulmonary function testing (PFT)
ELIGIBILITY
Age: >= 14 Years
FEV1: >= 40 Percent Predicted
P. aeruginosa status: Positive
B. cepacia status: Not applicable
Other Primary Eligibility Requirements:

Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
FOR MORE INFORMATION:
Sponsor Contact Information:
Trial Specific Link on ClinicalTrials.gov: Not Available
Clinical Research Terms Glossary: Click here
Back to top